Severe asthma, with an estimated prevalence of 5–10% in the total asthma population, impacts considerably on morbidity, mortality, and socioeconomic cost…

In recent decades, there has been growing interest in the recognition and management of both bronchiectasis and nontuberculous mycobacteria (NTM)…

National and European initiatives to drive quality improvement in chronic obstructive pulmonary disease (COPD)1,2 have led to integrated care models…

This symposium took place during the 2018 European Respiratory Society (ERS) International Congress in Paris, France and focussed on the disease burden…

Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide and is predicted to be the third leading cause of death by…

In December 2017, the National Institute for Health and Care Excellence (NICE) updated its interventional procedures guidance, titled ‘Endobronchial…

Current management of recurrent pleural effusion is symptomatic. Indwelling pleural catheters (IPC) reduce the initial length of hospital stay…

Asthma is currently characterised, in functional terms, as an inflammatory disorder linked to airway hyper-responsiveness that leads to symptoms….

Pleural disease is an increasingly common presentation and it has been estimated that up to 15% of patients have a metastatic pleural effusion at…

Noninvasive ventilation (NIV) is frequently used in patients with acute respiratory failure and its success is dependent on the underlying cause of the…